NeuroSense Therapeutics L...

AI Score

0

Unlock

1.02
-0.01 (-0.97%)
At close: Jan 15, 2025, 1:38 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -11.28M -12.34M -4.04M -2.83M -1.22M
Depreciation & Amortization 97.00K 89.00K 3.00K 3.00K n/a
Stock-Based Compensation 1.54M 5.11M 4.16M 2.06M 611.00K
Other Working Capital 928.00K 291.00K 289.00K 37.00K 6.00K
Other Non-Cash Items 1.30M -1.19M 791.00K -2.00K 591.00K
Deferred Income Tax -2.01M n/a -2.72M 2.00K n/a
Change in Working Capital 1.91M 750.00K 273.00K 69.00K 29.00K
Operating Cash Flow -8.45M -7.59M -1.54M -695.00K -582.00K
Capital Expenditures -29.00K -70.00K -17.00K -9.00K -7.00K
Acquisitions 3.00K n/a n/a n/a n/a
Purchase of Investments n/a -3.50M n/a n/a -19.00K
Sales Maturities Of Investments 3.50M n/a n/a n/a n/a
Other Investing Acitivies -6.00K 29.00K n/a n/a -19.00K
Investing Cash Flow 3.47M -3.54M -17.00K -9.00K -26.00K
Debt Repayment n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies -75.00K 3.69M 2.04M n/a -3.00K
Financial Cash Flow 3.90M 3.69M 11.90M 508.00K 1.42M
Net Cash Flow -903.00K -7.52M 10.36M -196.00K 809.00K
Free Cash Flow -8.48M -7.66M -1.56M -704.00K -589.00K